Organization Overview
Alternative names
autologous bone marrow derived mesenchymal cells (2 trials)
bone marrow derived mesenchymal stem cells (1 trial)
canrenone (Contaren) (1 trial)
"ex vivo" expanded autologous human oral epithelium containing stem cells (1 trial)
Acute Lung Injury (Phase 2)
Cataract (Phase 4)
Communicable Diseases (Phase 2)
Coronavirus Infections (Phase 2)
Dyspnea (Phase 2)
Eye Infections (Phase 4)
Infections (Phase 2)
Muscular Dystrophies (Phase 2)
Muscular Dystrophy, Duchenne (Phase 2)
Nephrosis (Phase 2)
Nephrotic Syndrome (Phase 2)
Pneumonia (Phase 2)
Pneumonia, Viral (Phase 2)
Respiratory Distress Syndrome (Phase 2)
Respiratory Distress Syndrome, Newborn (Phase 2)
Scleroderma, Diffuse (Phase 4)
Scleroderma, Localized (Phase 4)
Scleroderma, Systemic (Phase 4)
Severe Acute Respiratory Syndrome (Phase 2)
Shock (Phase 3)
Shock, Septic (Phase 3)
Stomach Neoplasms (Phase 3)
Syndrome (Phase 2)